Gene · 4882
Papers1,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High-throughput virtual screening, identification and in vitro biological evaluation of novel inhibitors of PLK1 and NRP1. | J Enzyme Inhib Med Chem | 2025 | 40820676 | PubTator, text mining | PubMed |
| Multimodal profiling reveals tissue-directed signatures of human immune cells altered with age. | Nat Immunol | 2025 | 40804529 | PubTator, text mining | PubMed |
| Experimental and numerical investigation of suddenly expanded flow at sonic mach number. | Sci Rep | 2025 | 40770029 | PubTator, text mining | PubMed |
| Regulation, effects and monitoring of compartmented cGMP signalling in cardiomyocytes-current status. | Br J Pharmacol | 2025 | 40751380 | PubTator, text mining | PubMed |
| Identification of NPR2 gene mutations affecting chondrocyte differentiation in short stature through JAK2-STAT5. | Orphanet J Rare Dis | 2025 | 40750885 | PubTator, text mining | PubMed |
| A Pan-Cancer Analysis of Natriuretic Peptide Receptor 3 (NPR3) with Clinical Cohort and in vitro Validation. | J Inflamm Res | 2025 | 40740975 | PubTator, text mining | PubMed |
| Genetics of short stature. | Curr Opin Pediatr | 2025 | 40658013 | PubTator, text mining | PubMed |
| Ultrasound-Guided Pleural Needle Biopsy Which Needle for Which Patient: A Prospective Randomized Study. | Balkan Med J | 2025 | 40619802 | PubTator, text mining | PubMed |
| Overexpression of CDCA2 in Diffuse Large B-Cell Lymphoma Promotes Cell Proliferation and Bortezomib Sensitivity. | Int J Mol Sci | 2025 | 40565058 | PubTator, text mining | PubMed |
| Optimizing C-Type Natriuretic Peptide and Receptor Expression Analysis with Droplet Digital™ PCR: Advancing Biomarker Discovery for Brugada Syndrome? | Biomolecules | 2025 | 40563432 | PubTator, text mining | PubMed |
| A novel variant in NPR2: C.2291T > C (p.Leu764Pro) identified in a patient with acromesomelic dysplasia Maroteaux type. | Ital J Pediatr | 2025 | 40551241 | PubTator, text mining | PubMed |
| Dual roles of IRE1α inhibition in reversing mitochondrial ROS-induced CD8+ T-cell senescence and exerting direct antitumor effects in multiple myeloma. | J Immunother Cancer | 2025 | 40425229 | PubTator, text mining | PubMed |
| Clinical Characteristics and Response to Growth Hormone Treatment in 27 Children With Heterozygous NPR2 Variants: Real-World Data. | J Clin Endocrinol Metab | 2025 | 40424589 | PubTator, text mining | PubMed |
| Examining the degree to which paranormal belief and conspiracy endorsement influence meaning in life: sequential mediating effects of creativity and self-esteem. | Front Psychol | 2025 | 40406615 | PubTator, text mining | PubMed |
| Associations of Genetically Predicted NPR3 and NPR2 Perturbation and Preeclampsia Risk: A Two-Sample Mendelian Randomization Analysis. | Int J Hypertens | 2025 | 40406480 | PubTator, text mining | PubMed |
| Two cases of autosomal dominant familial short stature associated with COL11A2 gene variant and the therapeutic response to recombinant human growth hormone. | Transl Pediatr | 2025 | 40386356 | PubTator, text mining | PubMed |
| Identification and functional analysis of NPR2 truncating mutations in two Chinese families with short stature. | BMC Pediatr | 2025 | 39994698 | PubTator, text mining | PubMed |
| An Innovative Approach to Tailor Sandwich Core Structures for Multi-Directional Loading Scenarios. | Materials (Basel) | 2025 | 39942265 | PubTator, text mining | PubMed |
| C-type natriuretic peptide promotes human granulosa cell growth and estradiol production: Implications for early follicle development. | Reprod Med Biol | 2025 | 39845482 | PubTator, text mining | PubMed |
| Endogenous C-type natriuretic peptide offsets the pathogenesis of steatohepatitis, hepatic fibrosis, and portal hypertension. | PNAS Nexus | 2025 | 39816244 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4882/papers?page=3